Associated Papers
G16R single nucleotide polymorphism but not haplotypes of the β(2)-adrenergic receptor gene alters cardiac output in humans.
Rokamp KZ et al.
Clinical Science (london, England : 1979), 2013
Genetic variation associated with ischemic heart failure: a HuGE review and meta-analysis.
Kitsios G et al.
American Journal of Epidemiology, 2007
Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets.
Insel PA et al.
Biochimica Et Biophysica Acta, 2007
A prospective evaluation of left ventricular remodeling after inaugural anterior myocardial infarction as a function of gene polymorphisms in the renin-angiotensin-aldosterone, adrenergic, and metalloproteinase systems.
Bauters C et al.
American Heart Journal, 2007
Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
Iaccarino G et al.
Clinical Pharmacology and Therapeutics, 2006
Is there a role of the Thr164Ile-beta(2)-adrenoceptor polymorphism for the outcome of chronic heart failure?
Leineweber K et al.
Basic Research in Cardiology, 2006
Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis.
Zee RY et al.
Journal of Thrombosis and Haemostasis : Jth, 2006
Genetic variation in G-protein-coupled receptors--consequences for G-protein-coupled receptors as drug targets.
Tang CM et al.
Expert Opinion on Therapeutic Targets, 2005
beta-2 adrenergic receptor gene variations, blood pressure, and heart size in normal twins.
Busjahn A et al.
Hypertension (dallas, Tex. : 1979), 2000
Select a paper to view details